Maximum Vyvanse Dose for a 22-Year-Old Male
The maximum recommended dose of Vyvanse (lisdexamfetamine) for a 22-year-old male is 70 mg once daily, taken in the morning. 1
FDA-Approved Dosing
The FDA label is unequivocal on this point. For ADHD treatment in adults:
- Starting dose: 30 mg once daily in the morning
- Titration: May be adjusted in increments of 10 mg or 20 mg at approximately weekly intervals
- Maximum dose: 70 mg once daily 1
This applies to all adults, including your 22-year-old male patient, regardless of gender or specific age within the adult range.
Clinical Context and Evidence
The 70 mg maximum is supported by multiple clinical trials in adults. Studies have demonstrated that doses of 30 mg, 50 mg, and 70 mg all show significant efficacy compared to placebo, with improvements noted within the first week of treatment 2. The dose-response relationship shows that higher doses generally provide greater symptom reduction, particularly in patients with more severe baseline ADHD symptoms 3.
Important caveat: While older guidelines mention that "consensus from practice is that doses may go higher than the PDR-recommended upper limits on rare occasions" for immediate-release amphetamines 4, this does NOT apply to Vyvanse. The FDA label for LDX explicitly states 70 mg as the maximum, and no clinical trials have evaluated doses above this threshold 3.
Renal Impairment Considerations
If your patient has renal impairment, the maximum dose is lower:
- Severe renal impairment (GFR 15-30): Maximum 50 mg daily
- End-stage renal disease (GFR <15): Maximum 30 mg daily 1
Practical Prescribing Algorithm
- Start at 30 mg once daily in the morning with or without food
- Assess response weekly using standardized rating scales and patient/family report
- Titrate by 10-20 mg increments if inadequate response
- Stop at 70 mg maximum - if symptoms are not controlled at this dose, consider switching medications rather than exceeding the maximum 1
- Monitor vital signs quarterly (blood pressure and pulse) 4
Why Not Higher?
The evidence base stops at 70 mg. Research explicitly states: "The results do not provide information about doses above 70 mg/d, which is the maximum approved dose of LDX and the highest dose studied in ADHD clinical trials" 3. Without safety and efficacy data beyond 70 mg, and with clear FDA guidance, exceeding this dose would be off-label prescribing without supporting evidence.
Bottom line: 70 mg once daily is the ceiling. Do not exceed it.